![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CTBP2 |
Gene summary for CTBP2 |
![]() |
Gene information | Species | Human | Gene symbol | CTBP2 | Gene ID | 1488 |
Gene name | C-terminal binding protein 2 | |
Gene Alias | CTBP2 | |
Cytomap | 10q26.13 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | P56545 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1488 | CTBP2 | GSM4909281 | Human | Breast | IDC | 7.16e-03 | 2.73e-01 | 0.21 |
1488 | CTBP2 | GSM4909286 | Human | Breast | IDC | 1.81e-06 | 2.02e-01 | 0.1081 |
1488 | CTBP2 | GSM4909292 | Human | Breast | IDC | 3.06e-04 | 5.82e-01 | 0.1236 |
1488 | CTBP2 | GSM4909293 | Human | Breast | IDC | 4.22e-16 | 3.77e-01 | 0.1581 |
1488 | CTBP2 | GSM4909297 | Human | Breast | IDC | 3.78e-03 | -4.30e-02 | 0.1517 |
1488 | CTBP2 | GSM4909311 | Human | Breast | IDC | 1.08e-13 | -9.96e-02 | 0.1534 |
1488 | CTBP2 | GSM4909312 | Human | Breast | IDC | 1.92e-03 | 1.10e-01 | 0.1552 |
1488 | CTBP2 | GSM4909319 | Human | Breast | IDC | 1.84e-16 | -2.26e-01 | 0.1563 |
1488 | CTBP2 | GSM4909320 | Human | Breast | IDC | 2.85e-03 | -1.59e-01 | 0.1575 |
1488 | CTBP2 | GSM4909321 | Human | Breast | IDC | 1.97e-06 | -4.44e-02 | 0.1559 |
1488 | CTBP2 | M2 | Human | Breast | IDC | 1.71e-05 | 5.16e-01 | 0.21 |
1488 | CTBP2 | M5 | Human | Breast | IDC | 2.71e-02 | 5.48e-01 | 0.1598 |
1488 | CTBP2 | NCCBC14 | Human | Breast | DCIS | 3.03e-08 | 2.18e-01 | 0.2021 |
1488 | CTBP2 | NCCBC2 | Human | Breast | DCIS | 3.76e-05 | 3.05e-01 | 0.1554 |
1488 | CTBP2 | NCCBC5 | Human | Breast | DCIS | 7.25e-05 | -9.37e-02 | 0.2046 |
1488 | CTBP2 | P1 | Human | Breast | IDC | 6.03e-09 | -1.64e-01 | 0.1527 |
1488 | CTBP2 | DCIS2 | Human | Breast | DCIS | 1.96e-60 | 5.15e-01 | 0.0085 |
1488 | CTBP2 | CCI_1 | Human | Cervix | CC | 9.50e-11 | 1.65e+00 | 0.528 |
1488 | CTBP2 | CCI_2 | Human | Cervix | CC | 1.39e-12 | 1.54e+00 | 0.5249 |
1488 | CTBP2 | CCI_3 | Human | Cervix | CC | 6.84e-20 | 1.43e+00 | 0.516 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005109828 | Thyroid | HT | regulation of binding | 56/1272 | 363/18723 | 6.41e-09 | 5.75e-07 | 56 |
GO:005109928 | Thyroid | HT | positive regulation of binding | 34/1272 | 173/18723 | 1.64e-08 | 1.30e-06 | 34 |
GO:004544417 | Thyroid | HT | fat cell differentiation | 29/1272 | 229/18723 | 8.88e-04 | 9.30e-03 | 29 |
GO:002240614 | Thyroid | HT | membrane docking | 13/1272 | 86/18723 | 5.19e-03 | 3.48e-02 | 13 |
GO:0016032113 | Thyroid | PTC | viral process | 236/5968 | 415/18723 | 2.48e-26 | 8.24e-24 | 236 |
GO:0051098113 | Thyroid | PTC | regulation of binding | 195/5968 | 363/18723 | 3.21e-18 | 3.37e-16 | 195 |
GO:0019058113 | Thyroid | PTC | viral life cycle | 167/5968 | 317/18723 | 8.87e-15 | 5.89e-13 | 167 |
GO:0051099113 | Thyroid | PTC | positive regulation of binding | 100/5968 | 173/18723 | 1.56e-12 | 6.96e-11 | 100 |
GO:0019079113 | Thyroid | PTC | viral genome replication | 74/5968 | 131/18723 | 4.85e-09 | 1.26e-07 | 74 |
GO:003052228 | Thyroid | PTC | intracellular receptor signaling pathway | 126/5968 | 265/18723 | 6.31e-08 | 1.31e-06 | 126 |
GO:002240615 | Thyroid | PTC | membrane docking | 48/5968 | 86/18723 | 3.72e-06 | 4.73e-05 | 48 |
GO:004544418 | Thyroid | PTC | fat cell differentiation | 102/5968 | 229/18723 | 3.66e-05 | 3.40e-04 | 102 |
GO:01400569 | Thyroid | PTC | organelle localization by membrane tethering | 40/5968 | 77/18723 | 1.98e-04 | 1.49e-03 | 40 |
GO:00508089 | Thyroid | PTC | synapse organization | 161/5968 | 426/18723 | 5.11e-03 | 2.36e-02 | 161 |
GO:199082310 | Thyroid | PTC | response to leukemia inhibitory factor | 42/5968 | 95/18723 | 7.69e-03 | 3.27e-02 | 42 |
GO:00482783 | Thyroid | PTC | vesicle docking | 28/5968 | 59/18723 | 8.85e-03 | 3.68e-02 | 28 |
GO:199083010 | Thyroid | PTC | cellular response to leukemia inhibitory factor | 41/5968 | 94/18723 | 1.10e-02 | 4.38e-02 | 41 |
GO:001603234 | Thyroid | ATC | viral process | 241/6293 | 415/18723 | 5.50e-25 | 2.04e-22 | 241 |
GO:005109834 | Thyroid | ATC | regulation of binding | 203/6293 | 363/18723 | 1.18e-18 | 1.55e-16 | 203 |
GO:001905835 | Thyroid | ATC | viral life cycle | 173/6293 | 317/18723 | 9.22e-15 | 5.50e-13 | 173 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0522010 | Breast | IDC | Chronic myeloid leukemia | 15/867 | 76/8465 | 9.24e-03 | 4.37e-02 | 3.27e-02 | 15 |
hsa0522013 | Breast | IDC | Chronic myeloid leukemia | 15/867 | 76/8465 | 9.24e-03 | 4.37e-02 | 3.27e-02 | 15 |
hsa0522023 | Breast | DCIS | Chronic myeloid leukemia | 15/846 | 76/8465 | 7.42e-03 | 3.48e-02 | 2.56e-02 | 15 |
hsa0522033 | Breast | DCIS | Chronic myeloid leukemia | 15/846 | 76/8465 | 7.42e-03 | 3.48e-02 | 2.56e-02 | 15 |
hsa043109 | Cervix | CC | Wnt signaling pathway | 43/1267 | 171/8465 | 3.03e-04 | 1.64e-03 | 9.68e-04 | 43 |
hsa0522014 | Cervix | CC | Chronic myeloid leukemia | 21/1267 | 76/8465 | 3.08e-03 | 1.19e-02 | 7.03e-03 | 21 |
hsa04330 | Cervix | CC | Notch signaling pathway | 17/1267 | 62/8465 | 7.99e-03 | 2.56e-02 | 1.51e-02 | 17 |
hsa0431012 | Cervix | CC | Wnt signaling pathway | 43/1267 | 171/8465 | 3.03e-04 | 1.64e-03 | 9.68e-04 | 43 |
hsa0522015 | Cervix | CC | Chronic myeloid leukemia | 21/1267 | 76/8465 | 3.08e-03 | 1.19e-02 | 7.03e-03 | 21 |
hsa043301 | Cervix | CC | Notch signaling pathway | 17/1267 | 62/8465 | 7.99e-03 | 2.56e-02 | 1.51e-02 | 17 |
hsa05220 | Colorectum | AD | Chronic myeloid leukemia | 31/2092 | 76/8465 | 1.41e-03 | 8.46e-03 | 5.39e-03 | 31 |
hsa04310 | Colorectum | AD | Wnt signaling pathway | 56/2092 | 171/8465 | 1.03e-02 | 3.93e-02 | 2.51e-02 | 56 |
hsa052201 | Colorectum | AD | Chronic myeloid leukemia | 31/2092 | 76/8465 | 1.41e-03 | 8.46e-03 | 5.39e-03 | 31 |
hsa043101 | Colorectum | AD | Wnt signaling pathway | 56/2092 | 171/8465 | 1.03e-02 | 3.93e-02 | 2.51e-02 | 56 |
hsa052202 | Colorectum | MSS | Chronic myeloid leukemia | 29/1875 | 76/8465 | 1.10e-03 | 6.27e-03 | 3.84e-03 | 29 |
hsa043102 | Colorectum | MSS | Wnt signaling pathway | 53/1875 | 171/8465 | 4.24e-03 | 1.86e-02 | 1.14e-02 | 53 |
hsa052203 | Colorectum | MSS | Chronic myeloid leukemia | 29/1875 | 76/8465 | 1.10e-03 | 6.27e-03 | 3.84e-03 | 29 |
hsa043103 | Colorectum | MSS | Wnt signaling pathway | 53/1875 | 171/8465 | 4.24e-03 | 1.86e-02 | 1.14e-02 | 53 |
hsa043104 | Colorectum | FAP | Wnt signaling pathway | 46/1404 | 171/8465 | 3.94e-04 | 3.06e-03 | 1.86e-03 | 46 |
hsa052204 | Colorectum | FAP | Chronic myeloid leukemia | 23/1404 | 76/8465 | 2.14e-03 | 1.05e-02 | 6.39e-03 | 23 |
Page: 1 2 3 4 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CTBP2 | SNV | Missense_Mutation | novel | c.2749N>T | p.His917Tyr | p.H917Y | P56545 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-C8-A12Q-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
CTBP2 | SNV | Missense_Mutation | c.2201C>T | p.Ala734Val | p.A734V | P56545 | protein_coding | deleterious(0.02) | possibly_damaging(0.563) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
CTBP2 | SNV | Missense_Mutation | novel | c.2648N>T | p.Arg883Leu | p.R883L | P56545 | protein_coding | deleterious(0.03) | possibly_damaging(0.608) | TCGA-C5-A1BF-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
CTBP2 | SNV | Missense_Mutation | c.2325G>C | p.Gln775His | p.Q775H | P56545 | protein_coding | tolerated(0.09) | benign(0.047) | TCGA-EK-A3GK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
CTBP2 | SNV | Missense_Mutation | c.1676C>T | p.Pro559Leu | p.P559L | P56545 | protein_coding | deleterious_low_confidence(0.01) | benign(0.137) | TCGA-EX-A69M-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD | |
CTBP2 | SNV | Missense_Mutation | novel | c.184C>G | p.Leu62Val | p.L62V | P56545 | protein_coding | deleterious_low_confidence(0.05) | benign(0.003) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
CTBP2 | SNV | Missense_Mutation | novel | c.1786A>T | p.Thr596Ser | p.T596S | P56545 | protein_coding | deleterious(0.03) | possibly_damaging(0.64) | TCGA-VS-A9UB-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
CTBP2 | SNV | Missense_Mutation | rs771702203 | c.2069N>T | p.Thr690Met | p.T690M | P56545 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-A6-3809-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CTBP2 | SNV | Missense_Mutation | novel | c.43N>G | p.Ser15Gly | p.S15G | P56545 | protein_coding | tolerated_low_confidence(0.17) | benign(0.065) | TCGA-AA-3715-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
CTBP2 | SNV | Missense_Mutation | c.1609C>T | p.Pro537Ser | p.P537S | P56545 | protein_coding | deleterious_low_confidence(0.05) | benign(0.015) | TCGA-AA-A01V-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |